Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 359-366

  Goulet, Jennifer L ^a,b   Griffiths, Robert C ^a   Ruiz, Phillip ^c   Spurney, Robert F ^a   Pisetsky, David S ^a   Koller, Beverly H ^b   Coffman, Thomas M ^a,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTHRITIS; ARTICLE; AUTOIMMUNITY; ENZYME DEFICIENCY; FEMALE; GENETIC VARIABILITY; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STRAIN DIFFERENCE; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARTHRITIS; AUTOANTIBODIES; FEMALE; GLOMERULAR FILTRATION RATE; INDOLES; KIDNEY; LIPOXYGENASE INHIBITORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RENAL CIRCULATION; SEX FACTORS;

EID: 0033168592     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568.
2. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway, biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645.
3. Henderson, W. R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684.
4. Dahlen, S.-E., J. Bjork, P. Hedqvist, K.-E. Arfors, S. Hammarstrom, J.-A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78:3887.
5. Lewis, R. A., and K. F. Austen. 1984. The biologically active leukotrienes, biosynthesis, metabolism, receptors, functions, and pharmacology. J. Clin. Invest. 73:889.
6. Dahlen, S.-E., P. Hedqvist, S. Hammarstrom, and B. Samuelsson. 1980. Leukotrienes are potent constrictors of human bronchi. Nature 288:484.
7. Drazen, J. M., and K. F. Austen. 1987. Leukotrienes and airway responses. Am. Rev. Respir. Dis. 136:985.
8. 4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. Br. J. Pharmacol. 72:389.
9. 2 in guinea-pig in vivo. Pharmacol. Res. Commun. 13:633.
10. 4: implications for the regulation of inflammatory responses. Br. J. Pharmacol. 110:423.
11. + lymphocyte phenotype and immunoregulatory functions. J. Immunol. 135: 1357.
12. Rola-Pleszczynski, M., and I. Lemaire. 1985. Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol. 135:3958.
13. 4-induced immunoregulation. J. Immunol. 139:513.
14. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. J. Exp. Med. 148:1198.
15. Hang, L., A. N. Theofilopoulos, and F. J. Dixon. 1982. A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J. Exp. Med. 155:1690.
16. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
17. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
18. Murphy, E. D., and J. B. Roths. 1978. Autoimmunity and lymphoproliferation: induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In Genetic Control of Autoimmune Disease. N. R. Rose, P. E. Bigazzi, and N. L. Warner, eds. Elsevier North Holland, p. 207.
19. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
20. Watson, M. L., J. K. Rao, G. S. Gilkeson, P. Ruiz, E. M. Eicher, D. S. Pisetsky, A. Matsuzawa, J. M. Rochelle, and M. F. Seldin. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645.
21. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
22. Izui, S., V. E. Kelley, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
23. Ahmed, S. A., W. J. Penhale, and N. Talal. 1985. Sex hormones, immune responses, and autoimmune diseases: mechanisms of sex hormone action. Am. J. Pathol. 121:531.
24. Lahita, R. G. 1986. The influence of sex hormones on the disease systemic lupus erythematosus. Springer Semin. Immunopathol. 9:305.
25. Pisetsky, D. S. 1986. Systemic lupus erythematosus. Adv. Rheumatol. 70:337.
26. Kelley, V. E., A. Ferretti, S. Izui, and T. B. Strom. 1985. A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. J. Immunol. 134:1914.
27. Kelley, V. E., S. Sneve, and S. Musinski. 1986. Increased renal thromboxane production in murine lupus nephritis. J. Clin. Invest. 77:252.
28. Spurney, R. F., P. Ruiz, D. S. Pisetsky, and T. M. Coffman. 1991. Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites. Kidney Int. 39:95.
29. Spurney, R. F., R. J. Bernstein, P. Ruiz, D. S. Pisetsky, and T. M. Coffman. 1991. Physiologic role for enhanced renal thromboxane production in murine lupus nephritis. Prostaglandins 42:15.
30. 4 by macrophages from autoimmune-prone mice. J. Exp. Med. 168:783.
31. 4. Can. J. Physiol. Pharmacol. 61:325.
32. 4 in the rat. Circ. Res. 54:492.
33. 4 on glomerular dynamics in the rat. Am. J. Physiol. 253:F239.
34. Allen, D. E., and M. Gellai. 1990. Hemodynamic responses to leukotriene receptor stimulation in conscious rats. Am. J. Physiol. 258:R1034.
35. Barnett, R., P. Goldwasser, L. A. Scharschmidt, and D. Schlondorff. 1986. Effects of leukotrienes on isolated rat glomeruli and cultured mesangial cells. Am. J. Physiol. 250:F838.
36. 4 contract rat glomerular mesangial cells. Kidney Int. 30:524.
37. 4 binding and signal transduction in rat glomerular mesangial cells. Am. J. Physiol. 257:F280.
38. 4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry 27:2846.
39. Goulet, J. L., J. N. Snouwaert, A. M. Latour, T. M. Coffman, and B. H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91:12852.
40. 1 a potent and specific leukotriene biosynthesis inhibitor, blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265:1436.
41. Miller, D. K., J. W. Gillard, P. J. Vickers, S. Sadowski, C. Leveille, J. A. Mancini, P. Charleson, R. A. F. Dixon, A. W. Ford-Hutchinson, R. Fortin, et al. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343:278.
42. Gilkeson, G. S., P. Ruiz, J. P. Grudier, R. J. Kurlander, and D. S. Pisetsky. 1989. Genetic control of inflammatory arthritis in congenic lpr mice. Clin. Immunol. Immunopathol. 53:460.
43. G-monomethyl-L-arginine. J. Exp. Med. 179:651.
44. Jancso-Gabor, A., J. Szolcsanyi, and N. Jancso. 1967. A simple method for measuring the amount of azovan blue exuded into the skin in response to an inflammatory stimulus. J. Pharm. Pharmacol. 19:486.
45. Chen, X.-S., T. A. Naumann, U. Kurre, N. A. Jenkins, N. G. Copeland, and C. D. Funk. 1995. cDNA cloning, expression, mutagenesis, intracellular localization, and gene chromosomal assignment of mouse 5-lipoxygenase. J. Biol. Chem. 270:17993.
46. Byrum, R. S., J. L. Goulet, R. J. Griffiths, and B. H. Koller. 1991. Role of the 5-lipoxygenase activating protein (FLAP) in murine acute inflammatory responses. J. Exp. Med. 185:1065.
47. 1 mice. Clin. Immunol. Immunopathol. 54:372.
48. Carlsten, H., A. Tarkowski, R. Holmdahl, and L.-A. Nilsson. 1990. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin. Exp. Immunol. 80:467.
49. Carlsten, H., N. Nilsson, R. Jonsson, K. Backman, R. Holmdahl, and A. Tarkowski. 1992. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell. Immunol. 144:190.
50. Steinberg, A. D., J. B. Roths, E. D. Murphy, R. T. Steinberg, and E. S. Raveche. 1980. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol. 125:871.
51. Shear, H. L., D. Wofsy, and N. Talal. 1983. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Clin. Immunol. Immunopathol. 26:361.
52. Pierucci, A., B. M. Simonetti, G. Pecci, G. Mavrikakis, S. Feriozzi, G. A. Cinotti, P. Patrignani, G. Ciabattoni, and C. Patrono. 1989. Improvement of renal function with selective thromboxane antagonism in lupus nephritis. N. Engl. J. Med. 320: 421.
53. Patrono, C., G. Ciabattoni, G. Remuzzi, E. Gotti, S. Bombardieri, O. Di Munno, G. Tartarelli, G. A. Cinotti, B. M. Simonetti, and A. Pierucci. 1985. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J. Clin. Invest. 76:1011.
54. Serhan, C. N. 1994. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta. 1212:1.